Ghana vs Thailand: HIV/AIDS deaths averted by antiretroviral therapy
Ghana
12,358 deaths
in 2024
Thailand
10,666 deaths
in 2024
Ghana rank
20th
Thailand rank
23rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Ghana
- Thailand
How they compare
Ghana currently reports 12,358 deaths against 10,666 deaths in Thailand, a difference of 1,692 deaths.
That makes Ghana's figure about 1.2 times Thailand's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Thailand ahead.
Ghana ranks 20th and Thailand ranks 23rd of 157 countries.
Thailand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Ghana | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 2.7 deaths | 2.7 deaths | Thailand |
| 2000s | 1,525 deaths | 13,768 deaths | 12,243 deaths | Thailand |
| 2010s | 9,063 deaths | 21,782 deaths | 12,719 deaths | Thailand |
| 2020s | 11,466 deaths | 12,351 deaths | 884.8 deaths | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Ghana or Thailand?
- Ghana, at 12,358 deaths against 10,666 deaths in Thailand as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Ghana and Thailand?
- 1,692 deaths, with Ghana ahead.
- How many years of comparable data are there for Ghana and Thailand?
- 35 years are reported by both, from 1990 to 2024.
- How do Ghana and Thailand rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Ghana ranks 20th and Thailand ranks 23rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.